Postmarket surveillance data revealed that enfortumab vedotin (EV) skin toxicity is associated with high hospitalization and ...

In the fight against disease, programmed cell death - also known as apoptosis - is a key protective function of the body. It breaks down cells that ...

LANZHOU -- Chinese researchers have revealed the heart-protective effect of nicotinamide — a derivative of B vitamins — in ...

Summit Therapeutics' Ivonescimab targets non-small cell lung cancer through its dual anti-PD-1 plus anti-VEGF mechanism.

In the fight against disease, programmed cell death – also known as apoptosis – is a key protective function of the body. It breaks down cells that are damaged or have undergone dangerous changes.

A new study finds that three existing drugs can force leukemia cells into necroptosis, activating a strong immune response.

Radiopharm completes enrollment for second cohort of patients in phase 1 dose escalation trial of 177Lu-RAD204 in PD-L1 positive advanced cancers: Sydney Saturday, November 15, 20 ...

Researchers uncovered a powerful weakness in lung cancer by shutting down a protein that helps tumors survive stress. When this protein, FSP1, was blocked, lung tumors in mice shrank dramatically, ...

LANZHOU, Nov. 5 (Xinhua) -- Chinese researchers have revealed the heart-protective effect of nicotinamide -- a derivative of B vitamins -- in exploring the mechanisms of related cardiotoxicity in ...

Agenus Inc. (“Agenus”) (Nasdaq: AGEN), a leader in immuno-oncology, today announced it will host its End-of-Year 2025 Stakeholder Webcast on Wednesday, December 3, 2025 at 4:00 p.m. ET. The session ...